CO2 Laser vs Lidocaine for Vestibulodynia in Premenopausal Women
Status:
Completed
Trial end date:
2021-01-31
Target enrollment:
Participant gender:
Summary
CO2 laser energy is currently used widely for the treatment of postmenopausal women who have
vaginal atrophy due to the lack of estrogen. However, its effect on premenopausal women with
hormonally-mediated vulvar vestibulodynia is unknown. This study seeks to evaluate the effect
of CO2 laser on young women and compare it to topical lidocaine.